Arix Bioscience plc
LSE: ARIX.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Tom Davidson
- Employees
- 9
- Headquarters
- London, United Kingdom
- IPO year
- 2017
- Market cap
- £183.7M
- Website
- https://arixbioscience.com
Loading ARIX…
Loading profile data…Frequently asked questions about ARIX
What does Arix Bioscience plc (ARIX.L) do?
Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical...
Where does ARIX.L trade?
Arix Bioscience plc (ARIX.L) trades on the London Stock Exchange.
What sector is ARIX.L in?
Arix Bioscience plc (ARIX.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Arix Bioscience plc?
Tom Davidson is the chief executive officer of Arix Bioscience plc (ARIX.L).
Where is Arix Bioscience plc headquartered?
Arix Bioscience plc is headquartered in United Kingdom.
Does ARIX.L pay a dividend?
Arix Bioscience plc (ARIX.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ARIX.L go public?
Arix Bioscience plc (ARIX.L) completed its initial public offering in 2017.